The civic record
Read. Follow. Verify.Louisiana requires health insurance plans to cover injectable drugs for glucose improvement and weight loss under specific conditions
Last action · March 9, 2026: Read by title, under the rules, referred to the Committee on Insurance.Sponsor: Rodney Lyons
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Louisiana House Bill 869 requires s issued or renewed in the state on or after January 1, 2026, to cover FDA-approved injectable drugs used to lower glucose levels or for weight loss when prescribed for prediabetes, gestational diabetes, or . Insurers may apply standard deductibles, copayments, prior authorization, and require participation in a lifestyle management plan.
Residents with prediabetes, gestational diabetes, or gain insurance access to FDA-approved injectable medications for weight loss and glucose management, subject to insurer formularies, medical necessity rules, and potential lifestyle program requirements.
- State legislatures frequently consider bills to mandate health insurance coverage for specific medical treatments, preventive services, and prescription medications. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
health insurance plan enrollees
Enrollees diagnosed with prediabetes, gestational diabetes, or obesity gain required insurance coverage for FDA-approved injectable drugs for glucose improvement and weight loss.
health insurance issuers
Health coverage plans must update their policies, contracts, and formularies to include coverage for qualifying injectable medications and may establish prior authorization or lifestyle management requirements.
licensed healthcare providers
Providers can prescribe FDA-approved injectable drugs for weight loss and glucose control under mandatory insurance coverage rules and may be asked to certify ongoing medical necessity.
Key Facts
- Health coverage plans renewed, delivered, or issued for delivery in Louisiana cannot deny coverage for injectable drugs used to lower glucose levels or for weight loss if approved by the FDA.
- The drug must be prescribed by a licensed healthcare provider for the treatment of prediabetes, gestational diabetes, or obesity, and be medically necessary.
- Covered drugs must be on the insurer's formulary or preferred drug list, if any.
- Health coverage plans may apply annual deductibles, coinsurance, copayment provisions, and prior authorization requirements.
Show all 7 facts
- Insurers may require continued medical necessity certification by the treating healthcare provider and mandatory participation in an available lifestyle management plan.
- The law applies to new policies, contracts, programs, or health coverage plans issued on and after January 1, 2026.
- Existing policies prior to January 1, 2026, must conform on or before their renewal date, but no later than January 1, 2027.
Frequently Asked Questions
Which medical conditions qualify a patient for covered injectable drugs under this bill?
Can health insurance companies still require prior authorization for these medications?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
4 actions- Mar 9, 2026HouseIntroducedRead by title, under the rules, referred to the Committee on Insurance.
- Feb 27, 2026HousePrefiled.
- Feb 27, 2026HouseCommitteeUnder the rules, provisionally referred to the Committee on Insurance.
- Feb 27, 2026HouseFirst appeared in the Interim Calendar on 2/27/2026.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Mandatory Coverage Expansion for Weight Loss and Glucose Drugs
The bill shifts health insurance obligations in Louisiana by requiring coverage for FDA-approved injectable drugs for weight loss and glucose control under specific diagnostic criteria.
Connected Entities
Sources
www.legis.la.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 65)
- Controversy50Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools